Skip to main content
background gradient

Volume 4Issue 3

Editorial

Free Access
Breast conserving therapy or mastectomy: a done deal or one worth returning to?
  • Isabelle Bedrosian and
  • Yu Shen
pp187–189
Published Online:11 May 2015

Commentary

Open Access
Bringing cohort studies to the bedside: framework for a ‘green button’ to support clinical decision-making
  • Blanca Gallego,
  • Scott R Walter,
  • Richard O Day,
  • Adam G Dunn,
  • Vijay Sivaraman,
  • Nigam Shah,
  • Christopher A Longhurst, and
  • Enrico Coiera
pp191–197
Published Online:11 May 2015
Preview Abstract

From Methods to Policy

Research Article

Free Access
Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments
  • Michael R Eber,
  • Dana P Goldman,
  • Darius N Lakdawalla,
  • Tomas J Philipson,
  • Daryl Pritchard,
  • Marco Huesch,
  • Nicholas Summers,
  • Mark T Linthicum,
  • Jeff Sullivan, and
  • Robert W Dubois
pp203–213
Published Online:7 May 2015
Preview Abstract
Free Access
Predictors of preoperative MRI for breast cancer: differences by data source
  • Elizabeth T Loggers,
  • Hongyuan Gao,
  • Laura S Gold,
  • Larry Kessler,
  • Ruth Etzioni,
  • Diana SM Buist, and
  • ADVICE Investigators
pp215–226
Published Online:11 May 2015
Preview Abstract
Free Access
Value of a small control group for estimating intervention effectiveness: results from simulations of immunization effectiveness studies
  • Sonja S Hutchins,
  • Cedric Brown,
  • Robert Mayberry, and
  • William Sollecito
pp227–238
Published Online:11 May 2015
Preview Abstract
Free Access
A comparative effectiveness analysis of treatment for latent tuberculosis infection using multilevel selection models
  • Kyle R Fluegge and
  • Brian E Roe
pp239–257
Published Online:12 May 2015
Preview Abstract
Free Access
Intramuscular hepatitis B immunoglobulins for reinfection control after liver transplantation: a cost-saving alternative
  • Eva Hulstaert,
  • Xavier Verhelst,
  • Anja Geerts, and
  • Hans Van Vlierberghe
pp259–265
Published Online:8 May 2015
Preview Abstract

Review

Free Access
Outcomes, costs and cost–effectiveness of treating hepatitis C with direct acting antivirals
  • Jona T Stahmeyer,
  • Siegbert Rossol, and
  • Christian Krauth
pp267–277
Published Online:11 May 2015
Preview Abstract
Open Access
Clinical and cost–effectiveness of insulin degludec: from clinical trials to clinical practice
  • Marc Evans and
  • Phil McEwan
pp279–286
Published Online:11 May 2015
Preview Abstract

Erratum

Free Access
Erratum
pp288–288
Published Online:9 April 2015